Villanueva ELA, Collado PSP

Language: Spanish
References: 20
Page: 57-61
PDF size: 73.25 Kb.

ABSTRACT

The pre-eclamptic syndrome is a major medical problem leading to substantial maternal and perinatal morbidity and mortality worldwide. The etiology is unknown, although may have a genetic predisposition or be associated with significant alterations in the immune response resulting in a multisystem disorder characterized by hypertension, proteinuria, and coagulation and/or liver function abnormalities. No single screening test or intervention to prevent preeclampsia has been found to be reliable and cost-effective. Treatment is still prenatal care, timely diagnosis, proper management, prevention of seizures and timely delivery. This review is an up-date in the diagnosis, risk factors, prediction, prevention, complications and management of the preeclampsia-eclampsia syndrome.

REFERENCES

1. Sibai B, Dekker G, Kupferminc. Pre-eclampsia. Lancet 2005; 365: 785-99.

2. Elu MC, Santos PE. Mortalidad materna: una tragedia evitable. Perinatol Reprod Hum 2004; 18: 44-52.

3. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209-15.

4. Ritchie LD, King JC. Dietary calcium and pregnancy-induced hypertension: is there a relation? Am J Clin Nutr 2000; 71(Suppl): 1371S-4S.

5. Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from observations to molecular mechanisms. Braz J Med Biol Res 2001; 34: 1227-1235.

6. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, Merialdi M. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynecol Obstet 2004; 85(Suppl. 1): S28-41.

7. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.

8. Mattar F, Sibai BM. Prevention of Pre-eclampsia. Semin Perinatol 1999; 23: 58-64.

9. Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 96: 8-20.

10. Chung NAY, Beevers DG, Lip GYH. Management of hypertension in pregnancy. Am J Cardiovasc Drugs 2001; 1: 253-62.

11. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. Int J Gynecol Obstet 2002; 77: 67-75.

12. Linton DM, Anthony J. Critical care management of severe pre-eclampsia. Intensive Care Med 1997; 23: 248-55.

13. Sibai BM. Magnesium sulfate prophylaxis in pre-eclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190: 1520-6.

14. Lu JF, Nightingale C. Magnesium sulfate in eclampsia and pre-eclampsia, pharmacokinetic principles. Clin Pharmacokinet 2000; 38: 305-14.

15. Norwitz ER, Hsu CD, Repke JT. Acute complications of pre-eclampsia. Clin Obstet Gynecol 2002; 45: 308-29.

16. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105: 402-10.

17. Montán S. Drugs use in hypertensive diseases in pregnancy. Curr Opin Obstet Gynecol 2004; 16: 111-5.

18. O’Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 2005; 48: 460-77.

19. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2005. Oxford: Update Software.

20. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002; 287: 3183-6.